Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 30 days ago
Share
A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
360 patients around the world
Available in
Spain, United States, Argentina
Bristol-Myers Squibb
1
Research sites
360
Patients around the world
This study is for people with
Psoriasis
Palmar-plantar psoriasis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
View site
Bulnes 1937, CABA, Buenos Aires
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
View site
Bulnes 1937, CABA, Buenos Aires
See details
Contact us
Contact us
Sponsor
Bristol-Myers Squibb
Conditions
Palmar-plantar psoriasis
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06042920
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent